Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −54,000−100.0% | Sold out | Holders |
| Q1 2024 | 54,000 | $3.17M | <0.1% | +54,000 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −1,068,143−100.0% | Sold out | Holders |
| Q2 2023 | 1,068,143 | $97.3M | 0.3% | +163,915+18.1% | Added | Holders |
| Q1 2023 | 904,228 | $59.6M | 0.2% | −228,395−20.2% | Reduced | Holders |
| Q4 2022 | 1,132,623 | $58.6M | 0.2% | +186,097+19.7% | Added | Holders |
| Q3 2022 | 946,526 | $64.6M | 0.2% | +946,526 | New | Holders |